Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice. (Q44024861)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice. |
scientific article |
Statements
Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice (English)
Bent Winding
Róisín NicAmhlaoibh
Henriette Misander
Pernille Høegh-Andersen
Thomas Levin Andersen
Claus Holst-Hansen
Niels Taekker Foged